Milestone Pharmaceuticals's total assets for Q1 2025 were $61.88M, a decrease of -18.03% from the previous quarter. MIST total liabilities were $68.01M for the fiscal quarter, a 9.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.